These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 8960580)

  • 1. Superiority of C-11 acetate compared with F-18 fluorodeoxyglucose in predicting myocardial functional recovery by positron emission tomography in patients with acute myocardial infarction.
    Rubin PJ; Lee DS; Dávila-Román VG; Geltman EM; Schechtman KB; Bergmann SR; Gropler RJ
    Am J Cardiol; 1996 Dec; 78(11):1230-5. PubMed ID: 8960580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of carbon-11-acetate with fluorine-18-fluorodeoxyglucose for delineating viable myocardium by positron emission tomography.
    Gropler RJ; Geltman EM; Sampathkumaran K; Pérez JE; Schechtman KB; Conversano A; Sobel BE; Bergmann SR; Siegel BA
    J Am Coll Cardiol; 1993 Nov; 22(6):1587-97. PubMed ID: 8227825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
    Baer FM; Voth E; Deutsch HJ; Schneider CA; Horst M; de Vivie ER; Schicha H; Erdmann E; Sechtem U
    J Am Coll Cardiol; 1996 Jul; 28(1):60-9. PubMed ID: 8752795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization.
    Knuuti MJ; Saraste M; Nuutila P; Härkönen R; Wegelius U; Haapanen A; Bergman J; Haaparanta M; Savunen T; Voipio-Pulkki LM
    Am Heart J; 1994 Apr; 127(4 Pt 1):785-96. PubMed ID: 8154416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial viability assessed with fluorodeoxyglucose and PET in patients with Q wave myocardial infarction receiving thrombolysis: relationship to coronary anatomy and ventricular function.
    Fragasso G; Chierchia SL; Rossetti E; Sciammarella MG; Conversano A; Lucignani G; Landoni C; Calori G; Margonato A; Fazio F
    Nucl Med Commun; 1997 Mar; 18(3):191-9. PubMed ID: 9106772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography.
    Fragasso G; Chierchia SL; Lucignani G; Landoni C; Conversano A; Gilardi MC; Colombo F; Rossetti C; Fazio F
    Am J Cardiol; 1993 Dec; 72(19):131G-139G. PubMed ID: 8279350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction.
    Wolpers HG; Burchert W; van den Hoff J; Weinhardt R; Meyer GJ; Lichtlen PR
    Circulation; 1997 Mar; 95(6):1417-24. PubMed ID: 9118508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of cardiac metabolism using radiolabelled glucose, fatty acids and acetate.
    Visser FC
    Coron Artery Dis; 2001 Feb; 12 Suppl 1():S12-8. PubMed ID: 11286301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early assessment of regional myocardial blood flow and metabolism in thrombolysis in myocardial infarction flow grade 3 reperfused myocardial infarction using carbon-11-acetate.
    Maes AF; Van de Werf F; Mesotten LV; Flamen PB; Kuzo RS; Nuyts JL; Mortelmans L
    J Am Coll Cardiol; 2001 Jan; 37(1):30-6. PubMed ID: 11153755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive assessment of myocardial viability by positron emission tomography with 11C acetate in patients with old myocardial infarction. Usefulness of low-dose dobutamine infusion.
    Hata T; Nohara R; Fujita M; Hosokawa R; Lee L; Kudo T; Tadamura E; Tamaki N; Konishi J; Sasayama S
    Circulation; 1996 Oct; 94(8):1834-41. PubMed ID: 8873657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism.
    Gropler RJ; Geltman EM; Sampathkumaran K; Pérez JE; Moerlein SM; Sobel BE; Bergmann SR; Siegel BA
    J Am Coll Cardiol; 1992 Sep; 20(3):569-77. PubMed ID: 1512335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional oxidative metabolism in patients after recovery from reperfused anterior myocardial infarction. Relation to regional blood flow and glucose uptake.
    Vanoverschelde JL; Melin JA; Bol A; Vanbutsele R; Cogneau M; Labar D; Robert A; Michel C; Wijns W
    Circulation; 1992 Jan; 85(1):9-21. PubMed ID: 1728489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism substrate with negative myocardial uptake of iodine-123-BMIPP.
    Kudoh T; Tamaki N; Magata Y; Konishi J; Nohara R; Iwasaki A; Ono S; Ohtake Y; Sugihara H; Sugihara H; Kuze K; Tsujimura Y; Miyazaki T
    J Nucl Med; 1997 Apr; 38(4):548-53. PubMed ID: 9098200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.
    Marshall RC; Tillisch JH; Phelps ME; Huang SC; Carson R; Henze E; Schelbert HR
    Circulation; 1983 Apr; 67(4):766-78. PubMed ID: 6600659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired myocardial tissue perfusion early after successful thrombolysis. Impact on myocardial flow, metabolism, and function at late follow-up.
    Maes A; Van de Werf F; Nuyts J; Bormans G; Desmet W; Mortelmans L
    Circulation; 1995 Oct; 92(8):2072-8. PubMed ID: 7554184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of myocardial circulation and metabolism using positron CT].
    Shishido F; Uemura K; Kanno I; Murakami M; Ono Y; Takahashi A
    J Cardiol Suppl; 1987; 15():61-3. PubMed ID: 3509906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of reduced regional myocardial glucose uptake in regions with normal blood flow in patients with chronic coronary artery disease.
    J Am Coll Cardiol; ; . PubMed ID: 8113542
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.